MUSETTE · BN42082
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A phase IIIb multicenter, randomized, double-blind, controlled study to evaluate the efficacy, safety and pharmacokinetics of a higher dose of ocrelizumab in adults with relapsing multiple sclerosis. EudraCT: 2020-000893-69
Sponsor: ROCHE
Phase: III
Area: Neuroimmunology